EFFECTS OF INTERFERON-BETA ON THE TRANSLOCATION RATE AND STATIONARY TIME IN HUMAN FIBROBLASTS IN CULTURE

被引:3
|
作者
MURPHY, JS
TAMM, I
机构
来源
CELL MOTILITY AND THE CYTOSKELETON | 1991年 / 19卷 / 02期
关键词
INHIBITION OF CELL MOTILITY AND PROLIFERATION BY INTERFERON-BETA; INTERFERON-BETA INCREASES STATIONARY TIME IN FIBROBLASTS; INTERFERON-BETA DECREASES TRANSLOCATION RATE IN FIBROBLASTS; FIBROBLAST MOTILITY IN CULTURE; CELL MOTILITY; TRANSLOCATION RATE AND STATIONARY TIME;
D O I
10.1002/cm.970190205
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The rate of translocation and the percent of the time that cells are stationary have been measured by computer-assisted time-lapse cinemicrography in over 1,000 freshly planted human foreskin fibroblasts (FS-4 cell strain) for periods of up to a week and the effects of interferon-beta (IFN-beta) on these parameters have been determined. Cells were planted at 2.5 x 10(3) cells/cm2 in Eagle's minimal essential medium (MEM) with 10% fetal bovine serum (FBS). Frames were taken every 2 or 4 minutes and data were collected on both cell location and cell division as a function of time. After planting FS-4 cells require approximately 48 hr to reach maximum motility both with respect to the translocation rate when moving and percent time cells are moving. Recombinant human IFN-beta (800-mu/ml) caused a marked increase in the fraction of time cells were stationary and a decrease of lesser magnitude in the translocation rate, as quantitated during the period during which the stationary fraction for control cells was at a minimum. IFN-beta also decreased the rate of cell proliferation, without any evidence of degeneration or death of cells. Our results contribute new evidence that the fraction of time cells spend moving directionally is an important determinant of their locomotory behavior and that this determinant is responsive to modulation by cytokines.
引用
收藏
页码:99 / 108
页数:10
相关论文
共 50 条
  • [21] INTERFERON-BETA TREATMENT OF HUMAN-DISEASE
    ALAM, JJ
    CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 688 - 691
  • [22] THE PRODUCTION AND TESTING OF RECOMBINANT HUMAN INTERFERON-BETA
    CREASEY, A
    DRUMMOND, R
    FERNANDES, P
    GEIGERT, J
    HANISCH, W
    KHOSROVI, B
    KUNITANI, M
    LIN, L
    MARK, D
    DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, 1985, 59 : 69 - 69
  • [23] ANTIVIRAL ACTION OF TNF IN HUMAN FIBROBLASTS REQUIRES THE PRESENCE OF SUBEFFECTIVE CONCENTRATIONS OF CLASSICAL INTERFERON-BETA
    REIS, LFL
    LEE, TH
    KOHASE, M
    ZHANG, Y
    LIN, JX
    FUJITA, T
    TANIGUCHI, T
    VILCEK, J
    REGULATION OF THE ACUTE PHASE AND IMMUNE RESPONSES : INTERLEUKIN-6, 1989, 557 : 540 - 542
  • [24] GROWTH INHIBITORY MECHANISM OF RECOMBINANT INTERFERON-BETA ON HUMAN GLIOMA-CELLS IN CULTURE
    YUNG, WKA
    STECK, PA
    MOSER, RP
    NISHIOKA, K
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 235 - 235
  • [25] EFFECTS OF HUMAN RECOMBINANT INTERFERON-ALPHA2, INTERFERON-BETA AND INTERFERON-GAMMA ON GROWTH AND SURVIVAL OF HUMAN CANCER NODULES MAINTAINED IN CONTINUOUS ORGANOTYPIC CULTURE
    BEAUPAIN, R
    BILLARD, C
    FALCOFF, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (02): : 141 - +
  • [26] IN-VITRO IMMUNOMODULATING EFFECTS OF INTERFERON-BETA
    REP, MHG
    HINTZEN, RQ
    POLMAN, CH
    VANLIER, RAW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 153 - 153
  • [27] IMMUNOSUPPRESSIVE EFFECTS OF HUMAN PLACENTAL TROPHOBLAST INTERFERON-BETA ON LYMPHOCYTES IN-VITRO
    ZDRAVKOVIC, M
    ABOAGYEMATHIESEN, G
    ZACHAR, V
    TOTH, FD
    DALSGARD, AM
    HAGER, H
    EBBESEN, P
    PLACENTA, 1994, 15 (06) : 591 - 600
  • [28] EFFECTS OF INTERFERON-ALPHA, INTERFERON-BETA, AND INTERFERON-GAMMA ON HUMAN INTERLEUKIN-2 PRODUCTION
    ROSZTOCZY, I
    SIROKI, O
    BELADI, I
    JOURNAL OF INTERFERON RESEARCH, 1986, 6 (05): : 581 - 589
  • [29] Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells
    AbdulAhad, AK
    Galazka, AR
    Revel, M
    Biffoni, M
    Borden, EC
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1997, 3 (01) : 27 - 32
  • [30] Recombinant human interferon-beta in the treatment of condylomata acuminata
    Dinsmore, W
    Jordan, J
    OMahony, C
    Harris, JRW
    McMillan, A
    Radcliffe, KW
    Engrand, P
    Jackson, BW
    Galazka, AR
    ABdulAhad, AK
    Illingworth, JM
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (10) : 622 - 628